Non-Cochrane · intervention · PM41809116

Collagen Supplementation for Skin and Musculoskeletal Health: An Umbrella Review of Meta-Analyses on Elasticity, Hydration, and Structural Outcomes.

Ravindran Roshan, Pizzol Damiano, López-Gil José Francisco, et al. · Aesthetic surgery journal. Open forum · 2026 · PubMed · doi:10.1093/asjof/ojag018

Findings

59 findings

Population
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMuscle architectureSMD 0.39 [0.15, 0.63]
Moderate
5 studies · 183 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMuscle soreness (48 hours)
48 hours
SMD 0.10 [-0.41, 0.60]
Low
5 studies · 122 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationTendon mechanical propertiesSMD 0.04 [-0.57, 0.64]
Low
4 studies · 127 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMaximal strength recovery (48 hours)
48 hours
SMD 0.30 [-0.05, 0.65]
Low
4 studies · 114 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationReactive strength recovery (24 hours)
24 hours
SMD 0.26 [-0.09, 0.61]
Low
4 studies · 114 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationTendon morphologySMD 0.65 [0.04, 1.26]
Low
4 studies · 127 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMaximal strengthSMD 0.18 [0.02, 0.34]
High
11 studies · 533 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationImmediate muscle soreness
immediately post-exercise
SMD -0.21 [-0.57, 0.15]
Low
4 studies · 104 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationReactive strength recovery (48 hours)
48 hours
SMD 0.26 [-0.09, 0.61]
Low
4 studies · 114 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMaximal strength recovery (24 hours)
24 hours
SMD 0.26 [-0.09, 0.61]
Low
4 studies · 114 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationMuscle soreness (24 hours)
24 hours
SMD -0.06 [-0.45, 0.33]
Low
4 studies · 114 participants
Participants in RCTs of collagen supplementation (muscle, tendon and exercise-recovery outcomes)Collagen supplementationPlacebo or no collagen supplementationFat-free massSMD 0.48 [0.21, 0.75]
Moderate
8 studies · 454 participants
Participants in RCTs of collagen use (oral health and periodontal outcomes)Collagen supplementationPlacebo or no collagen supplementationKeratinized mucosa width (KMW) parameterSMD -0.42 [-1.05, 0.20]
Moderate
7 studies · 266 participants
Participants in RCTs of collagen use (oral health and periodontal outcomes)Collagen supplementationPlacebo or no collagen supplementationParticipant aesthetic satisfactionSMD 6.42 [-6.32, 19.16]
Very low
2 studies · 100 participants
Participants in RCTs of collagen use (oral health and periodontal outcomes)Collagen supplementationPlacebo or no collagen supplementationProbing depth parameterSMD -0.08 [-0.21, 0.05]
Moderate
4 studies · 184 participants
Participants in RCTs of collagen use (oral health and periodontal outcomes)Collagen supplementationPlacebo or no collagen supplementationGingival thickness parameterSMD -0.44 [-0.71, -0.17]
Low
3 studies · 110 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationHDL-cSMD 2.73 [-1.43, 6.90]
Moderate
4 studies · 267 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationBody fat mass (%)SMD -0.55 [-1.47, 0.36]
Moderate
5 studies · 329 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationBody fat mass (kg)SMD -1.21 [-2.13, -0.29]
Moderate
4 studies · 254 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationFat free mass (kg)SMD 0.67 [-0.26, 1.59]
Moderate
4 studies · 254 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationFat free mass (%)SMD 1.49 [0.57, 2.42]
Low
3 studies · 192 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationBody mass indexSMD -1.01 [-2.15, 0.12]
Moderate
6 studies · 388 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationFasting blood glucoseSMD -7.18 [-19.60, 5.25]
High
5 studies · 338 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationDBPSMD -0.05 [-2.73, 2.63]
Moderate
4 studies · 285 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationHbA1cSMD -0.24 [-0.72, 0.24]
Very low
2 studies · 156 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationSBPSMD -4.03 [-8.89, 0.83]
Moderate
4 studies · 285 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationLDL-cSMD -1.08 [-8.65, 6.50]
Moderate
4 studies · 267 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationTGSMD -4.67 [-13.10, 3.76]
Moderate
4 studies · 267 participants
Participants in RCTs of collagen supplementation (body composition and cardiometabolic outcomes)Collagen supplementationPlacebo or no collagen supplementationTotal CholesterolSMD -1.24 [-11.33, 8.86]
High
6 studies · 368 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationPain reductionSMD -0.35 [-0.47, -0.22]
High
25 studies · 2687 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationWOMAC (pain)SMD -0.74 [-1.61, 0.14]
High
10 studies · 1086 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationLesquene indexSMD -2.71 [-5.68, 0.26]
Very low
2 studies · 80 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationWOMAC (stiffness)SMD -0.53 [-0.83, -0.23]
High
7 studies · 595 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationAdverse events (osteoarthritis)OR 1.66 [0.99, 2.79]
Moderate
4 studies · 474 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationWOMAC (functional limitation)SMD -1.96 [-5.87, 1.94]
High
8 studies · 969 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationWOMAC (index)SMD -7.24 [-10.24, -4.23]
High
18 studies · 1322 participants
Individuals with osteoarthritis in RCTs of collagen supplementationCollagen supplementationPlacebo or no collagen supplementationVAS (score)SMD -10.13 [-19.88, -0.38]
High
7 studies · 572 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin hydration (arbitrary unit)SMD 0.32 [-0.50, 1.14]
Very low
2 studies · 37 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous hydration (arbitrary unit)SMD 0.31 [-0.51, 1.13]
Very low
2 studies · 37 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin hydration (µm)SMD 0.72 [0.19, 1.26]
Moderate
5 studies · 275 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin elasticitySMD 1.01 [0.44, 1.59]
High
20 studies · 1217 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin roughnessSMD -0.73 [-1.55, 0.09]
High
8 studies · 513 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous elasticity (%)SMD -0.27 [-2.30, 1.77]
High
6 studies · 384 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin hydration (%)SMD 2.56 [-2.56, 7.67]
Very low
2 studies · 184 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous elasticity (arbitrary unit)SMD 0.31 [-0.54, 1.15]
Moderate
4 studies · 161 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationAdverse events (skin)RR 0.76 [0.50, 1.15]
High
6 studies · 555 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationSkin hydrationSMD 0.71 [0.44, 0.99]
High
19 studies · 954 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous elasticityRR 1.20 [-0.81, 3.22]
High
13 studies · 767 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous elasticity (MPa)SMD 4.67 [-0.04, 9.38]
Moderate
4 studies · 342 participants
Participants in RCTs of collagen supplementation (skin elasticity, hydration and roughness)Collagen supplementationPlacebo or no collagen supplementationCutaneous hydration (µm)SMD 0.86 [0.27, 1.45]
Moderate
4 studies · 244 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenArea reduction (%)SMD 1.11 [0.34, 1.87]
Low
4 studies · 187 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenAdverse events (during healing)OR 0.72 [0.45, 1.13]
High
5 studies · 493 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenComplete wound healingOR 1.66 [0.89, 3.11]
High
7 studies · 1534 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenWound healing rateRR 1.43 [1.24, 1.64]
High
11 studies · 961 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenWounds closed (%)OR 3.78 [0.90, 15.83]
High
7 studies · 1492 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenArea reduction (wound)SMD 0.61 [0.11, 1.11]
Very low
2 studies · 78 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenWound relative reduction (%)SMD 13.49 [4.87, 22.10]
Moderate
4 studies · 173 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenRecurrence of ulcerationRR 0.39 [0.12, 1.25]
Moderate
3 studies · 425 participants
Participants with skin wounds or ulcers in studies of collagen (collagen dressing)CollagenPlacebo, standard care or no collagenHealing velocitySMD 4.02 [-1.22, 9.26]
Very low
2 studies · 91 participants

Included primary studies 15

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Chen 2023
matched by author and year (probable)
NR4 other reviewsnot statednot extracted yet
Kumar 2023
matched by author and year (probable)
NR1 other reviewnot statednot extracted yet
Zhang 2021
matched by author and year (probable)
NR1 other reviewnot statednot extracted yet
Bischof 2024
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Chicone 2018
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Chowdhry 2022
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
de Miranda 2021
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Garcia-Coronado 2019
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
García-Coronado 2019
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Jalili 2023
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Liang 2024
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Moraschini 2020
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Simental-Mendia 2025
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Simental-Mendía 2025
matched by author and year (probable)
NRthis review onlynot statednot extracted yet
Van Vijven 2012
matched by author and year (probable)
NRthis review onlynot statednot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationAny human participantsHuman participants (n=7983 across 113 RCTs); muscle, oral health, cardiometabolic, osteoarthritis, skin and wound outcomes
InterventionAny collagen supplementationCollagen supplementation (16 systematic reviews with meta-analysis)
ComparisonPlacebo or no collagen supplementationPlacebo or no collagen supplementation
OutcomesAll health outcomesMuscle, oral health, cardiometabolic, osteoarthritis and skin outcomes (59 pooled estimates)
Study designsSystematic reviews with meta-analysis of RCTsRCTs (n=113); a few wound estimates also included case-control or cohort studies
TimingNot specifiedNot specified